The interesting times gimmick has gotten old Finn. You don't need a signature on HC.
I'm not sure about the shots fired at healthpro here Finnigan. Even if he works at Arnotts and consults to Airguide, his points are spot on. For long termers, the following is starting to make this stock look like Anna Kournikova; looks good, doesn't win.
- Continuing to make a meal out of capital raising with the same brokerage parties, connected to the same board member.
- Asking for performance rights that effectively lower the burden of performance
- Failing to deliver key milestones in a timely manner
Additionally;
FA change is required for a re-rate of FFX. We're all holding thumbs for the mining forecast. While I personally see this as a cashflow positive exploration play with a functioning gold plant, we're being traded as a producer with only a tailings resource. The SOI and our capital partners are to blame.
I'm personally bullish on gold, I expect 2000's next year. However if cash printing reduces and economies start to unravel I suspect there will be a rush to cash; which we saw this year which correlated with a GP drop probably circa US$1,600; not the end of the world, as company is viable at these levels.
For FFX, what was true yesterday is true today;
- Lithium is a fantastic deposit.
- Gold exploration potential for enterprise levels of value is significant
- Gold resource upgrade near existing mine civil infrastructure is imminent , significant and correlates with immediate cash in the bank.
- Both commodity outlooks are strong.
This is a strong buy without having to call out down ramping where there is none and ignore important criticism where there is plenty to be noted.
- Forums
- ASX - By Stock
- FFX
- Ann: Firefinch Celebrates First Gold Pour
Ann: Firefinch Celebrates First Gold Pour, page-224
-
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online